Evidence map›Paper›PMID 28948305›Full record

ArticleDiabetologia2017

Erratum to: Understanding and preventing type 1 diabetes through the unique working model of TrialNet.

Manuela Battaglia, Mark S Anderson, Jane H Buckner, Susan M Geyer, Peter A Gottlieb, Thomas W H Kay, Åke Lernmark, Sarah Muller, Alberto Pugliese, Bart O Roep and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetologia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Manuela BattagliaDiabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy. battaglia.manuela@hsr.it.
Mark S AndersonDiabetes Center, University of California, San Francisco, CA, USA.
Jane H BucknerTranslational Research Program, Benaroya Research Institute, Seattle, WA, USA.
Susan M GeyerHealth Informatics Institute, University of South Florida, Tampa, FL, USA.
Peter A GottliebBarbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, CO, USA.
Thomas W H KaySt Vincent's Institute, Fitzroy, VIC, Australia.
Åke LernmarkLund University/CRC, Department of Clinical Sciences, Skane University Hospital, Malmö, Sweden.
Sarah MullerHealth Informatics Institute, University of South Florida, Tampa, FL, USA.
Alberto PuglieseDiabetes Research Institute, Department of Medicine, Division of Diabetes Endocrinology and Metabolism, Department of Microbiology and Immunology, Leonard Miller School of Medicine University of Miami, Miami, FL, USA.
Bart O RoepDepartment of Diabetes Immunology, Diabetes & Metabolism Research Institute, Beckman Research Institute at the City of Hope, Duarte, CA, USA.
Carla J GreenbaumDiabetes Program Benaroya Research Institute, Seattle, WA, USA.
Mark PeakmanDepartment of Immunobiology, Faculty of Life Sciences & Medicine, King's College London, London, SE1 9RT, UK. mark.peakman@kcl.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28948305
PMCPMC6828087

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.